Jenny Karlsson

Company: Bayer

Job title: Head of TRP Biochemistry

Bio:

14 years industrial experience of research and development of antibody-based therapies, protein engineering and conjugation technologies, with a PhD in Biochemistry from Göteborgs University. Currently at the Targeted Radiopharmaceutical department, Bayer AS, focusing on targeted alpha therapy (TAT) with three targeted thorium conjugates (TTCs) in clinical Phase I.